免疫系统和瘤之间的战争 - 使用免疫生物标志物作为标记物
Kai Yang1, Rongrong Lu1, Jie Mei1
1Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, P. R. China.
Biomarker research
|May 30, 2024
概括
免疫生物标志物对于预测和监测癌症免疫疗法疗效至关重要. 准这些标志物可以增强个性化的治疗策略,并改善抗瘤反应.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物标志物发现发现
背景情况:
- 免疫疗法是主要的抗瘤策略.
- 免疫生物标志物预测免疫疗法的疗效,副作用,并监测瘤免疫反应.
- 新的免疫生物标志物正在癌症治疗的临床试验中出现.
研究的目的:
- 通过抗瘤免疫的镜头系统地审查瘤发生和癌症进展.
- 探索瘤抗原表达,天生的免疫力和癌症免疫循环.
- 评估影响瘤免疫力的新兴因素,以实现综合癌症管理.
主要方法:
- 对瘤发生和抗瘤免疫的系统文献综述.
- 分析瘤抗原表达和天生的免疫力.
- 评估影响瘤免疫力的代谢,微生物和运动相关因素.
主要成果:
- 免疫生物标志物是理解瘤免疫性和先天免疫力的不可或缺的一部分.
- 新兴的因素,如代谢,微生物和运动标记,影响瘤免疫力.
- 临床研究表明,免疫生物标志物在癌症治疗中的应用.
结论:
- 免疫生物标志物是开发精确和个性化的癌症免疫疗法的关键.
- 生物标志物有助于预测,监测和调节瘤免疫反应.
- 针对免疫生物标志物提供了在瘤学中创新的临床应用的潜力.
相关概念视频
01:27Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K